Jiangsu (SH:688426) Shang Hai Zheng Quan Bao·2026-02-24 17:05Core Viewpoint - Jiangsu Kangwei Century Biotechnology Co., Ltd. has announced a change in its continuous supervision sponsor representative due to the work transition of the previous representative, Yang Ling, ensuring the orderly continuation of supervision work [1][2]. Group 1: Company Announcement - The company received a letter from CITIC Securities regarding the replacement of the continuous supervision sponsor representative [1]. - Yang Ling and Jiang Hao were originally appointed as the sponsor representatives for the company's initial public offering (IPO) project, with supervision lasting until December 31, 2025 [1]. - Wang Wei has been appointed to replace Yang Ling as the new sponsor representative, alongside Jiang Hao, to continue fulfilling the relevant duties and obligations of continuous supervision [1]. Group 2: Acknowledgment - The company's board expressed sincere gratitude for Yang Ling's contributions during the continuous supervision period of the IPO project [2]. Group 3: New Sponsor Representative Profile - Wang Wei holds a master's degree and currently serves as a senior vice president of the Investment Banking Management Committee at CITIC Securities [3]. - He has been involved in several major projects, including the IPOs of Ruili Kemi and Kangwei Century, as well as other financing and acquisition projects [3].